Adzenys ER™ (amphetamine) – New formulation approval
September 15, 2017 – Neos Therapeutics announced the FDA approval of Adzenys ER (amphetamine) oral suspension for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older.
Download PDF
